一般論文
近年の日本の医薬品市場動向とCubixx®システムの有用性についての検討
キーワード:
Cubixx,
inventory management,
specialty medicines,
medical economics,
pharmaceutical market,
refrigerated management
2021 年 47 巻 9 号 p. 477-489
詳細
2021 年 47 巻 9 号 p. 477-489
The Cubixx® system seamlessly monitors the storage status of medicines by using wireless networks, enabling the return and lot exchange of medicines stored under non-room temperature conditions, which was generally impossible previously. To evaluate the availability of the Cubixx® system, we surveyed recent trends in the Japanese pharmaceutical market, status of pharmaceutical purchases, and status of the use of the Cubixx® system in Yokohama City University Hospital.
The Japanese pharmaceutical market continued to grow from 2007 to 2019 (P < 0.001). There are 11 pharmaceutical therapeutic categories (hereinafter referred to as “correlated categories”) that have a statistically positive correlation with the expansion of the total output (P < 0.001). In the targeted period, most medicines newly listed on the NIH price list (67.9％) belong to correlated categories, and the ratio of injection medicines stored at non-room temperature which are expensive has increased. 96.7％ of A-ranked medicines with ABC analysis in Yokohama City University Hospital are injection medicines, which tend to be expensive and stored at non-room temperature. 85％ of A-ranked items belong to correlated categories. Due to the use of the Cubixx® system, the targeted medicines were never discarded during the targeted period. The total amount of returned medicines during the period accounted for 62.3％ of the total.
The recent Japanese pharmaceutical market has continued to grow, with the increase in newly released injection medications which belong to correlated categories, are stored at non-room temperature, and expensive. The Cubixx® system may be useful in the inventory management of these medicines.
